糖皮质激素在脓毒症治疗中的研究进展

被引：13

作者：

李志华

刘宣

葛勤敏

王海嵘

潘曙明

机构：

[1] 上海交通大学医学院附属新华医院急诊科

来源：

现代生物医学进展 | 2015年 / 15卷 / 21期

关键词：

脓毒症; 脓毒性休克; MODS; 糖皮质激素;

D O I：

10.13241/j.cnki.pmb.2015.21.053

中图分类号：

R459.7 [急症、急救处理];

学科分类号：

100231 [临床病理学];

摘要：

脓毒症是由致病微生物感染引发的全身炎症反应综合征(SIRS),合并血压降低且经快速液体复苏后血压仍不能恢复正常者称为脓毒性休克(Septic shock),其中一部分患者发展为多器官功能障碍综合症(MODS)。脓毒症病死率居高不下。每10万人口中约50-300人会发生严重脓毒症,其短期死亡率达20%-25%,当发展为脓毒性休克时其死亡率达50%。整合消灭致病微生物、阻断炎症介质和处理MODS等措施的"集束化"治疗并未显著降低脓毒症患者的病死率。糖皮质激素具有强大的抗炎作用,但诸多的临床研究对糖皮质激素疗效的评价褒贬不一,糖皮质激素是否有利于脓毒症的转归一直饱受争议[3]。本文仅就糖皮质激素在严重脓毒症及脓毒性休克中的治疗进展综述如下,并希望能进一步探讨发生严重脓毒症及脓毒性休克时,机体对糖皮质激素反应复杂性的原因,以及在以后的研究中对相对肾上腺皮质功能不全的诊断标准及对糖皮质激素用药和停药时机的选择更加明确。

引用

收藏

页码：4191 / 4193+4197 +4197

页数：4

相关论文

共 14 条

[1]

Low-Dose Hydrocortisone Therapy Attenuates Septic Shock in Adult Patients but Does Not Reduce 28-Day Mortality: A Meta-Analysis of Randomized Controlled Trials [J].

Wang, Changsong ;

Sun, Jiaxiao ;

Zheng, Juanjuan ;

Guo, Lei ;

Ma, Hongyan ;

Zhang, Yang ;

Zhang, Fengmin ;

Li, Enyou .

ANESTHESIA AND ANALGESIA, 2014, 118 (02) :346-357

[2]

Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012 [J].

Dellinger, R. P. ;

Levy, Mitchell M. ;

Rhodes, Andrew ;

Annane, Djillali ;

Gerlach, Herwig ;

Opal, Steven M. ;

Sevransky, Jonathan E. ;

Sprung, Charles L. ;

Douglas, Ivor S. ;

Jaeschke, Roman ;

Osborn, Tiffany M. ;

Nunnally, Mark E. ;

Townsend, Sean R. ;

Reinhart, Konrad ;

Kleinpell, Ruth M. ;

Angus, Derek C. ;

Deutschman, Clifford S. ;

Machado, Flavia R. ;

Rubenfeld, Gordon D. ;

Webb, Steven ;

Beale, Richard J. ;

Vincent, Jean-Louis ;

Moreno, Rui .

INTENSIVE CARE MEDICINE, 2013, 39 (02) :165-228

[3]

Sepsis, Systemic Inflammatory Response, and Multiple Organ Dysfunction: The Mystery Continues [J].

Fry, Donald E. .

AMERICAN SURGEON, 2012, 78 (01) :1-8

[4]

Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock [J].

Russell, James A. ;

Walley, Keith R. ;

Gordon, Anthony C. ;

Cooper, James ;

Hebert, Paul C. ;

Singer, Joel ;

Holmes, Cheryl L. ;

Mehta, Sangeeta ;

Granton, John T. ;

Storms, Michelle M. ;

Cook, Deborah J. ;

Presneill, Jeffrey J. .

CRITICAL CARE MEDICINE, 2009, 37 (03) :811-818

[5]

Adjunctive therapies in severe sepsis and septic shock: Current place of steroids [J].

Keh D. ;

Weber-Carstens S. ;

Ahlers O. .

Current Infectious Disease Reports, 2008, 10 (5) :354-361

[6]

Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 [J].

Dellinger, R. Phillip ;

Levy, Mitchell M. ;

Carlet, Jean M. ;

Bion, Julian ;

Parker, Margaret M. ;

Jaeschke, Roman ;

Reinhart, Konrad ;

Angus, Derek C. ;

Brun-Buisson, Christian ;

Beale, Richard ;

Calandra, Thierry ;

Dhainaut, Jean-Francois ;

Gerlach, Herwig ;

Harvey, Maurene ;

Marini, John J. ;

Marshall, John ;

Ranieri, Marco ;

Ramsay, Graham ;

Sevransky, Jonathan ;

Thompson, B. Taylor ;

Townsend, Sean ;

Vender, Jeffrey S. ;

Zimmerman, Janice L. ;

Vincent, Jean-Louis .

INTENSIVE CARE MEDICINE, 2008, 34 (01) :17-60

[7]

Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock [J].

Oppert, M ;

Schindler, R ;

Husung, C ;

Offermann, K ;

Gräf, KJ ;

Boenisch, O ;

Barckow, D ;

Frei, U ;

Eckardt, KU .

CRITICAL CARE MEDICINE, 2005, 33 (11) :2457-2464

[8]

Septic shock [J].

Annane, D ;

Bellissant, E ;

Cavaillon, JM .

LANCET, 2005, 365 (9453) :63-78

[9]

Relative adrenal insufficiency in critical illness [J].

Martin, LG ;

Groman, RP .

JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE, 2004, 14 (03) :149-157

[10]

Time for a consensus definition of corticosteroid insufficiency in critically ill patients *.[J].Djillali Annane.Critical Care Medicine.2003, 6